Developmental regression, absent speech, growth delay, microcephaly, feeding difficulties, no/poor eye-eye contact and respiratory problems were frequently described in COXPD21 patients, which should be added in OMIM phenotypic spectrum of COXPD21 [1, 9–13]. This evidence concerns the gene TARS2 and microcephaly.